About the Product

Description


Pitamore 4 Tablet containing Pitavastatin is used for the management of elevated cholesterol levels and lipid disorders. It helps improve lipid profiles and supports long-term cardiovascular health and risk reduction.

Pitavastatin works as an HMG-CoA reductase inhibitor (statin) that reduces cholesterol synthesis in the liver, helping lower LDL cholesterol and improve overall lipid balance while supporting cardiovascular wellness.

The tablet is widely prescribed in cardiology and general medicine practice for hyperlipidemia, mixed dyslipidemia, and cardiovascular risk management, leading to consistent prescription demand.

With the increasing prevalence of lifestyle-related cardiovascular disorders and growing demand for advanced lipid-lowering therapies, this product offers strong business potential for retailers and distributors. Its established therapeutic efficacy, broad clinical relevance, and steady market demand make it a reliable product for growth in the cardiovascular care segment.

Some patients may experience headache, muscle pain, joint pain, abdominal discomfort, nausea, constipation, diarrhea, or fatigue. Rarely, liver function abnormalities, myopathy, rhabdomyolysis, or severe allergic reactions may occur and require immediate medical attention.

Pitamore 4 Tablet is indicated for hypercholesterolemia, mixed dyslipidemia, elevated LDL cholesterol, and prevention of cardiovascular complications in patients at increased risk of heart disease. It helps control cholesterol levels and supports long-term cardiovascular protection.

This medicine should be used strictly under medical supervision. Regular monitoring of lipid levels and liver function may be necessary during treatment. Use cautiously in patients with liver disease, kidney impairment, excessive alcohol consumption, or a history of muscle disorders. Patients should continue following a cholesterol-lowering diet and healthy lifestyle measures while on therapy.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Pitavastatin 4mg Tablet in the PCD pharma franchise market?

Pitavastatin 4mg Tablet has strong demand in the cardiology, lipid management, and chronic care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on cardiovascular healthcare portfolios.

Why should medical distributors include Pitavastatin 4mg Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for cholesterol management and cardiovascular risk reduction under medical supervision. Pitavastatin 4mg belongs to the statin class of medications and helps lower elevated cholesterol levels Commonly prescribed for hyperlipidemia, dyslipidemia, and cardiovascular risk management as determined by healthcare professionals Helps reduce LDL (bad cholesterol) levels and supports overall cardiovascular health Widely prescribed by cardiologists, diabetologists, and general physicians for long-term lipid management This strengthens a comprehensive cardiology and chronic care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Pitavastatin 4mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong prescription demand, long-term therapy usage, repeat monthly purchases, reliable supply chain support, and attractive margins in the cardiovascular care segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.